School of Pharmacy
Menu
Publications
| S.No | Year wise |
|---|---|
| 1 | 2024-25 |
| 2 | 2023-24 |
| 3 | 2022-23 |
| 4 | 2021-22 |
| 5 | Patents |
| 6 | Books Published |
| 7 | Books-Chapters Published |
Research Areas
Pharmaceuical Sciences
- Pharmaceutical Formulations
- Pharmaceutical Analysis
- Pharmacology
- Pharmaceutical Biotechnology
- Nanotechnology
- Industrial Pharmacy
- Clinical Research
| S.No | Financial Year | Name of faculty Co-Ordinator | Title of Research project | Amount received (in Rupees) | Scheme |
|---|---|---|---|---|---|
| 1 | 2023-24 | Dr.Vasudha Bakshi | Enhancement of pharmacodynamic potential via receptor-targeted codelivery of Talazoparib and Docetaxel Nano-systems to suppress Triple-Negative Breast Cancer Progression: Implication analysis of formulation technologies, in-vitro and Pharmacokinetic aspects | 29,50,000/- | SERB POWER |
| 2 | 2022-23 | Dr. Krishna Prasad | Neuroprotective effect Nigellidine in Type 2 Diabetes mellitus associated with Alzheimer’s Disease | Rs.2,00,000/- | SEED Project |
| 3 | 2022-23 | Dr. K Sunand | Study of Novel Phytomolecules Alone and In Combination with Antidiabetic Agents to Ameliorate Diabetes-associated Alzheimer’s In Wistar Rats. | Rs.2,00,000/- | SEED Project |
| 4 | 2022-23 | Dr. D Mohanty | Development Optimisation and Biological evaluation of Functionalized Drug loaded zinc oxide nano Particle for Breast cancer therapy | Rs.2,00,000/- | SEED Project |
| 5 | 2022-23 | Dr. Ananda Kumar Chettupalli | An QBD Approach for Optimisation of vesicular Carrier for Brain Target through intranasal route of antipshychotic drugs | Rs.2,00,000/- | SEED Project |
| 6 | 2022-23 | Dr. B Hemanth | Functional and molecular characterization of a mutation in a depalmitoylating enzyme ABHD17a that is protective against alzmeimers Disease | 17,93,316/- | SERB-Sire |
| 7 | 2022-23 | Madhuri R | Ligand based design and synthesis of novel Tucatinib-MX106 derived hybrid analogues to target HER2 and Survivin dual inhibition via SMAC/DIABLO activation of caspases in therapeutic resistant advanced breast cancers: A new paradigm for targeted therapy. | Rs45,04,400/-Sanctioned 15,01,500-First Year Grant | DHR-Woman Scientist |
| 8 | 2021-22 | Dr.Vasudha Bakshi | Molecular Docking Study and Synthesis of Novel Cytoxic Quinazoline Derivatives | Rs.2,00,000/- | SEED Project |
| 9 | 2021-22 | Dr. G Baba Shankar Rao | Bio-guided Isolation and Evaluation of Novel Phytomolecules” for Anti-asthmatic activity from Galphimia glauca Cav. aerial parts employing Customized Fabricated Extractor | Rs.2,00,000/- | SEED Project |
| 10 | 2021-22 | Dr.Jagatram Bhavani Vasudha | Combating EGFR and HER2 associated multidrug resistance with novel terazosin analogues in metastatic breast cancers: Exploring drug repurposing to fulfill an unmet need in breast cancer treatment” | Rs.11,65,290/- (sanctioned: 45,89,235/-) | DHR |
| 11 | 2019-20 | Dr.Vasudha Bavani | Design And Development Of Nose-To-Brain Drug Delivery Systems | Rs.19,92,389/- (sanctioned: 20,22,730/-) | AICTE RPS |
| 12 | 2018-19 | Dr.Kiran Gangarapu | Design, Synthesis and Biological Evaluation of Monocarboxylate Transporter Inhibitors as Novel Anticancer Agents | Rs.8,00,000/- (sanctioned: 10,00,000/-) | AICTE MODROBS |
Funding Projects
| S.No | Name of faculty (Chief Consultant) | Project Title | Funding Agency | Amount | Duration |
|---|---|---|---|---|---|
| 1 | Dr. G. Kiran | Repurposing of Drugs for Anti-Urolithiatic activity by In silico, Invitro and In vivo methods. | PM-USHA | 6,56,250/- | 10 Months |
| 2 | Dr. P. Naveen | Computational screening of potential cyto-protective NRF2 pathway modulators | SEED Project | 2,00,000/- | 2 Years |
| 3 | Dr. K. Sunand | Study of Novel Phytomolecules Alone and In Combination with Antidiabetic Agents to Ameliorate Diabetes-associated Alzheimer’s In Wistar Rats | SEED Project | 2,00,000/- | 2 Years |
| 4 | Dr. Dibya Lochan Mohanty | Development Optimisation and Biological evaluation of Functionalized Drug loaded zinc oxide nano Particle for Breast cancer therapy | SEED Project | 2,00,000/- | 2 Years |
| 5 | Dr. Anand Kumar Chettupalli | An QBD Approach for Optimisation of vesicular Carrier for Brain Target through intranasal route of antipshychotic drugs | SEED Project | 2,00,000/- | 2 Years |
| 6 | Dr. D. Krishna Prasad | Neuroprotective effect Nigellidine in Type 2 Diabetes mellitus associated with Alzheimer’s Disease | SEED Project | 2,00,000/- | 2 Years |
| 7 | Dr. Hemanth Kumar | Functional and Molecular Characterization of Mutation in the Depalmitoyating Enzyme ABHD17a that is Protective against Alzheimer’s Disease | ANRF, New Delhi | 17,93,216/- | 6 Months |
| 8 | Mrs. Madhuri Rudraraju | Ligand based design and synthesis of novel Tucatinib-MX106 derived hybrid analogues to target HER2 and Survivin dual inhibition via SMAC/DIABLO activation of caspases in therapeutic resistant advanced breast cancers: A new paradigm for targeted therapy. | ICMR Women Scientist | 45,04,500/- | 3 Years |
| 9 | Mrs. Madhuri Rudraraju | Bridge Course and Training Programmee for the Employees of MSN Laboratories | MSN Laboratories | 19,92,000/- | 1 Year |
| 10 | Dr. G. Kiran | Molecular Dynamic Simulation of Methotrexate Drug with silver nanoparticle in drug Delivery across Cell membrane | NumFOCUS, Dallas | 96,000/- | 2 Months |
| 11 | Dr. Hemanth Kumar | 19th World Congress Basic and Clinical Pharmacology, Scotland | ICMR | 1,99,878/- | 2 Months |
| 12 | Dr.G.Kiran | Repurposing of Drug Molecules for Anti Urolithiatic Activity by in Silico, in vitro and in vivo methods | USHA | 6,56,250/- | 10 Months |
Consultancy Projects
| S.No | Name of faculty (Chief Consultant) | Project Title | Funding Agency | Amount | Duration |
|---|---|---|---|---|---|
| 1 | Dr. Vasudha Bakshi | Bridge Course and Training Programmee for the Employees of Hetero Drugs Pvt. Ltd | Hetero Drugs Private Limited | 12,48,000/- | 1 Year |
| 2 | Dr. K. Rama Devi | Isolation and Evaluation of Anti-Diabetic activity of Plant constituents | Clintech Analytics Private Limited | 1,90,000/- | 1 Year |
| 3 | Dr. Vasudha Bakshi | Bridge Course and Training Programmee for the Employees of MSN Laboratories | MSN Laboratories | 11,76,000/- | 1 Year |
| 4 | Dr Krishna Prasad | Docking and Anti-inflammatory activities of Plant constituents | S N Pharma | 2,16,000/- | 4 Months |
| 5 | Dr A Madhu Babu | Pharmaco-kinetic and Bio analytical studies of herbal formulation | Clintech Analytics Private Limited | 2,30,000/- | 4 Months |
| 6 | Dr B Vasudha | Screening of herbal compounds for Anti-inflammatory and analgesic activity | Green Evolution Laboratories | 2,00,000/- | 1 Year |
| S.No | Financial Year | Name of faculty (Chief Consultant) | Client Organization | Title of Consultancy of project | Amount received (in Rupees) |
|---|---|---|---|---|---|
| 1 | 2021-22 | Dr.Vasudha Bakshi | Nuvistas Laboratories | Immuno Modulatory activity and anti-activity alongwith toxicity studies of the given plant extracts | 1,80,000/- |
| Dr.Akiful Haque | Aptus Therapeutics | Development and Evaluation of Topical gel aswell as Niosomal gel of selected drugs | 2,20,000/- | ||
| 2 | 2020-21 | Dr A Madhu Babu | S N Pharma | Docking and Anti tumor activities of Plant constituents | 2,50,000/- |
| Dr B Vasudha | Green Evolution Laboratories | Isolation and Evaluation of Anti-Diabetic acitivity of Plant constituents | 2,00,000/- | ||
| 3 | 2019-20 | 1. Dr. Akiful Haque | Clintech Solutions | Preparation and Evaluation of Anti Diabetic Drug Loaded Nano Particles | Rs.3,00,000/- |
| 2. Dr.A.Madhu Babu | Syndy Pharma | Anti Dandruff Gel Preparations from Natural Products | Rs.3,00,000/- | ||
| 4 | 2018-19 | 1. Dr.B.Vasudha | Green Evoluation Laboratories | Synthesis and Characterization of Natural Products – Anacardic Acid | Rs.1,80,000/- |
| 2. Dr.A.Madhu Babu | S.N.Pharma | Formulation Development and Characterization of Novel Ethosomes | Rs.2,50,000/- | ||
| 5 | 2017-18 | 1. Dr.B.Vasudha | Innosyn Life Sciences Pvt.Ltd. | Antimicrobial Studies for the Biogensis of Rafamycyns | Rs.80,000/- |
| 2.Dr.B.Vasudha | Green Evaluation Laboratories | Screening of Compounds for Anti-inflamatory Activities | Rs.35,000/- |
Faculty Guiding Ph.D
| S.No | Name of the faculty | Research Students |
|---|---|---|
| 1 | Dr.Vasudha Bakshi | 8 |
| 2 | Dr. G.Kiran | 8 |
| 3 | Dr.Akiful Haque | 6 |
| 4 | Dr.M.Ram Mohan | 6 |
| 5 | Dr. D.Krishna Prasad | 6 |
| 6 | Dr.G.Baba Shaker Rao | 6 |
| 7 | Dr. Jainendra Kumar B. | 6 |
| 8 | Dr. P. Naveen | 4 |
| 9 | Dr. D. Sireesha | 6 |
| 10 | Dr. D. Mohanty | 6 |
| 11 | Dr. Sunand Katta | 3 |
| 12 | Dr. Mohammed Sayeed | 3 |
| 13 | Dr. Swapna S | 3 |
| 14 | Dr. J. Rajendra Kumar | 4 |
| 15 | Dr. K. Ramadevi | 5 |
| 16 | Dr. Ravi Sheshala | 3 |
| 17 | Dr. Azmath Farhana | 2 |
Faculty Pursuing Ph.D
| S.No | Name of the faculty | Area of research | Name of the University |
|---|---|---|---|
| 1 | A. Teja Sri | Design, Synthesis and Molecular Docking | VISTAS |
| 2 | P. Mary | Neuroprotective activity | Anurag University |
| 3 | B.Nirosha | Nano drug delivery system | Anurag University |
| 4 | D.K.Shanthi Priya | Analytical method development and validation of selected drugs by HPLC and lcms/ms methods | Gitam University |
| 5 | K. Mounika | Novel drug delivery, targated drug delivery | Annamalai Univeristy |
| 6 | G.Dharmender | Novel formulations in Hepatocellular Carcinoma Therapy | Anurag university |
| 7 | P.Himabindu | Nanovesicular elastic carriers for treatment of hypertension. | GITAM deemeed to be University |
| 8 | G.Rajeev Kumar | Assessment of Quality of Life After Novel Coronavirus nfection (COVID-19) and an empirical study on safety of Novel COVID-19 vaccines based on various Adverse Event Reporting System (AERS) | Anurag University |
| 9 | P.Venkateswara Rao | Pharmacological screening of novel phytomolecules | Anurag University |
| 10 | T.Maneswar | Design, Microwave assisted synthesis and pharmacological screening of novel azole moities | Anurag University |
| 11 | B.Ramudu | Inflammation and Neurological disorder | Anurag University |
| 12 | A.Ramgopal | Design and synthesis of novel trisubstituted triazolo quinazolinone analogues as promising antimicrobial and anti-tubercular agents | Osmania University |
| 13 | D. Lavanya | Forced drug degradation studies | Anurag University |
| 14 | Bushra Fathima | Nano formulation's | Anurag University |
| 15 | Syed Fatima Jabeen | Neuroprotective activity of novel compounds in Diabetes associated Alzheimers disease | Anurag University |
| 16 | G. Sai Charan | Pharmaceutical Analysis | Anurag University |
| 17 | Madhuri Rudra Raju | Cancer therapy | JNTUH |
